Improvement in fasting lipids but minimal recovery of limb fat were seen 96 weeks after switching from lamivudine/zidovudine (CBV) plus efavirenz (EFV) to fixed-dose efavirenz/emtricitabine/tenofovir df (ATR) in hiv-infected patients

Authors
Category Primary study
JournalCanadian Journal of Infectious Diseases and Medical Microbiology
Year 2010
This article has no abstract
Epistemonikos ID: ab269e7dfee2d5082706754ed220034eb3fe3e73
First added on: Feb 04, 2025